TM6SF2 and hepatocellular carcinoma: The result suggested that TM6SF2 gene mutation of E167K may promote DNA replication and accelerate cell cycle of human hepatocellular carcinoma cell line HEPA 1–6 and thereby promote the development of liver cancer cells.